In case of immunotherapies targeted against TAMs conducted on lung cancer in an in vivo murine model by administering it via intratracheal instillation, the administration of anti-VEGF siRNA gold nanoparticle for lung cancer could not only result in a dramatic reduction of TAMs in the tumor but decrease the size of the tumor as well. The gene discussed is VEGFA; the disease is neoplasm.